On June 10, 2022 Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, reported that President and CEO Robert E. Hoffman will present a corporate overview at the JMP Securities Life Sciences Conference (Press release, Kintara Therapeutics, JUN 10, 2022, View Source [SID1234615868]). The conference is being held on June 15 – 16, 2022 at the Lotte New York Palace Hotel.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation at the JMP Securities Life Sciences Conference will be available on View Source A replay of the webcast will be available for 30 days after the date of the presentation.

Mr. Hoffman will be available for one-on-one meetings with registered attendees of the conference.